Guggenheim Capital’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-23,553
| Closed | -$148K | – | 1924 |
|
|
2022
Q4 | $148K | Buy |
23,553
+6,630
| +39% | +$46.3K | ﹤0.01% | 1845 |
|
|
2022
Q3 | $117K | Sell |
16,923
-505
| -3% | -$3.51K | ﹤0.01% | 1836 |
|
|
2022
Q2 | $146K | Buy |
17,428
+5,769
| +49% | +$80.6K | ﹤0.01% | 1984 |
|
|
2022
Q1 | $266K | Sell |
11,659
-5,713
| -33% | -$140K | ﹤0.01% | 1931 |
|
|
2021
Q4 | $480K | Buy |
17,372
+6,875
| +65% | +$184K | ﹤0.01% | 1700 |
|
|
2021
Q3 | $292K | Buy |
10,497
+2,019
| +24% | +$57.3K | ﹤0.01% | 1921 |
|
|
2021
Q2 | $249K | Buy |
+8,478
| New | +$257K | ﹤0.01% | 2082 |
|
|
2020
Q4 | – | Sell |
-14,393
| Closed | -$224K | – | 2048 |
|
|
2020
Q3 | $224K | Sell |
14,393
-7,188
| -33% | -$124K | ﹤0.01% | 1740 |
|
|
2020
Q2 | $395K | Buy |
+21,581
| New | +$380K | ﹤0.01% | 1520 |
|
|
2020
Q1 | – | Sell |
-12,546
| Closed | -$375K | – | 1856 |
|
|
2019
Q4 | $375K | Buy |
12,546
+532
| +4% | +$13.8K | ﹤0.01% | 1722 |
|
|
2019
Q3 | $263K | Sell |
12,014
-3,661
| -23% | -$83.8K | ﹤0.01% | 1900 |
|
|
2019
Q2 | $395K | Sell |
15,675
-7,744
| -33% | -$184K | ﹤0.01% | 1759 |
|
|
2019
Q1 | $578K | Sell |
23,419
-3,790
| -14% | -$90.5K | ﹤0.01% | 1613 |
|
|
2018
Q4 | $503K | Sell |
27,209
-2,738
| -9% | -$65.1K | ﹤0.01% | 1672 |
|
|
2018
Q3 | $769K | Buy |
29,947
+10,510
| +54% | +$241K | 0.01% | 1756 |
|
|
2018
Q2 | $452K | Sell |
19,437
-8,074
| -29% | -$167K | ﹤0.01% | 2004 |
|
|
2018
Q1 | $438K | Buy |
27,511
+9,127
| +50% | +$170K | ﹤0.01% | 2416 |
|
|
2017
Q4 | $382K | Sell |
18,384
-16,271
| -47% | -$258K | ﹤0.01% | 2427 |
|
|
2017
Q3 | $497K | Buy |
34,655
+2,657
| +8% | +$40.2K | ﹤0.01% | 2389 |
|
|
2017
Q2 | $553K | Buy |
31,998
+9,213
| +40% | +$110K | ﹤0.01% | 2370 |
|
|
2017
Q1 | $251K | Buy |
22,785
+5,245
| +30% | +$72.2K | ﹤0.01% | 2579 |
|
|
2016
Q4 | $255K | Buy |
17,540
+2,752
| +19% | +$50.5K | ﹤0.01% | 2638 |
|
|
2016
Q3 | $363K | Sell |
14,788
-616
| -4% | -$15.9K | ﹤0.01% | 2500 |
|
|
2016
Q2 | $310K | Sell |
15,404
-16,647
| -52% | -$471K | ﹤0.01% | 2530 |
|
|
2016
Q1 | $842K | Buy |
32,051
+9,996
| +45% | +$739K | ﹤0.01% | 2154 |
|
|
2015
Q4 | $2.24M | Buy |
22,055
+3,857
| +21% | +$433K | 0.01% | 1538 |
|
|
2015
Q3 | $3.25M | Sell |
18,198
-9,955
| -35% | -$2.32M | 0.01% | 1275 |
|
|
2015
Q2 | $6.25M | Buy |
28,153
+5,135
| +22% | +$1.14M | 0.02% | 1051 |
|
|
2015
Q1 | $4.57M | Sell |
23,018
-2,700
| -10% | -$479K | 0.01% | 1204 |
|
|
2014
Q4 | $3.68M | Buy |
25,718
+7,898
| +44% | +$1.06M | 0.01% | 1299 |
|
|
2014
Q3 | $2.34M | Buy |
17,820
+1,770
| +11% | +$211K | 0.01% | 1647 |
|
|
2014
Q2 | $2.02M | Sell |
16,050
-3,450
| -18% | -$440K | 0.01% | 1812 |
|
|
2014
Q1 | $2.57M | Buy |
19,500
+5,660
| +41% | +$774K | 0.01% | 1576 |
|
|
2013
Q4 | $1.63M | Sell |
13,840
-7,130
| -34% | -$781K | ﹤0.01% | 1938 |
|
|
2013
Q3 | $2.19M | Sell |
20,970
-15,490
| -42% | -$1.51M | 0.01% | 1557 |
|
|
2013
Q2 | $3.2M | Buy |
+36,460
| New | +$2.87M | 0.01% | 1269 |
|
Other funds holding BHC
IC
PC
GAM
LCM
Guggenheim Capital's BHC Position: Q1 2023 in Review
Guggenheim Capital sold out of Bausch Health (BHC) in Q1 2023, closing a stake of 23,553 shares — an estimated $148K sold.
Guggenheim Capital first reported a position in BHC in Q2 2013 and held it in 36 quarters. The position peaked at $6.25M in Q2 2015. 235 funds tracked by Wall St. Rank hold BHC as of Q1 2023.
- Guggenheim Capital reported no remaining Bausch Health position as of Q1 2023 after selling out during the quarter.
- Guggenheim Capital sold 23,553 Bausch Health shares in Q1 2023, an estimated $148K.
- Guggenheim Capital first reported a position in Bausch Health in Q2 2013 and held it in 36 quarters.
- Guggenheim Capital's Bausch Health position peaked at $6.25M in Q2 2015.
- 235 funds tracked by Wall St. Rank held Bausch Health as of Q1 2023.
Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.